subgroup of
drug)
→
ReceivesAction
→
used in combination
| Typicality: | 0.280 |
| Saliency: | 0.071 |
| on the market | 4 | location |
| with other hepatitis b drugs | 2 | other |
| new drug → be used in → combination | 4 |
| negative | neutral | positive |
| 0.283 | 0.483 | 0.233 |
| Raw frequency | 4 |
| Normalized frequency | 0.071 |
| Modifier score | 0.500 |
| Perplexity | 33.289 |